Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

WHAT'S NEW

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jan 28 2021

Full Issue

Popular Medications Cost 2.5 Times More In the US Than Elsewhere

Yet more evidence of how much more Americans pay for prescription drugs is revealed in a survey, while pharmaceutical companies make little progress helping poor Americans afford them.

Stat: U.S. Drug Prices More Than Twice As High Than In 32 Other Countries

As debate intensifies over the cost of medicines, a new analysis found that prescription drug prices were on average 2.5 times more expensive in the U.S. than in 32 other countries. That gap widened to 3.4 times costlier when looking specifically at brand-name medications. (Silverman, 1/28)

Stat: Pharma Is Making Slow Progress On Access In Low-Income Countries

Like the proverbial tortoise, a new analysis finds that while the pharmaceutical industry is taking steps to provide access to its medicines, it is doing so at a slower pace than is needed for lower-income countries. The most notable sign of progress is in the R&D planning stages, as more drug makers are thinking ahead about access issues. (Silverman, 1/27)

In other pharmaceutical industry news —

FiercePharma: Nostrum Labs Adds Another NDMA-Tainted Metformin Lot To Its Growing Recall

2020's metformin recalls have bled into the new year. Just this week, Nostrum Laboratories, which already extended a product pull earlier this month, put another lot on the chopping block thanks to familiar contamination fears. Monday, Nostrum said it had recalled another lot of its 750-mg extended release metformin tablets due, once again, to higher-than-allowed levels of the possible carcinogen N-nitrosodimethylamine (NDMA). The move extends a metformin recall Nostrum issued in November, which the company first expanded in early January when it yanked another single lot of the popular diabetes med. (Kansteiner, 1/26)

Stat: Coalition Calls For Opioid Settlement Funds To Go To Evidence-Based Efforts

As state and local governments consider how to spend proceeds from settlements with opioid makers, a coalition of medical societies and advocacy groups is urging public officials to create dedicated funds to help people with substance use disorders, rather than fix holes in their budgets. (Silverman, 1/27)

Also —

Stat: A Thermostat For Blood Pressure Could Help Patients With Spinal Cord Injuries

Paralysis or the loss of mobility are among the most pressing and clear consequences of a spinal cord injury. But many patients also face lesser-known complications that can disrupt their daily lives in other ways. One of the most common problems is orthostatic hypotension, or not being able to maintain a stable blood pressure when switching positions between sitting, standing, or lying down. (Gaffney, 1/27)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF